AstraZeneca-Ionis drug fails to meet main goal in late-stage heart disease trial
AstraZeneca PLC
Ionis Pharmaceuticals, Inc.
AstraZeneca PLC AZN | 0.00 | |
Ionis Pharmaceuticals, Inc. IONS | 0.00 |
July 9 (Reuters) - AstraZeneca AZN.L said on Thursday that its drug Wainua, made in partnership with Ionis IONS.O, failed to meet the main goal of reducing cardiovascular deaths and recurring heart problems in a late-stage trial.